<it>ERCC2 </it>2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: A preliminary study

<it>ERCC2 </it>2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: A preliminary study

<p>Abstract</p> <p>Background</p> <p>Early relapse in colorectal cancer (CRC) patients is attributed mainly to the higher malignant entity (such as an unfavorable genotype, deeper tumor invasion, lymph node metastasis and advance cancer stage) and poor response to chemo...

Full description

Bibliographic Details
Main Authors:	Lee Su-Chen, Fang Wei-Yu, Huang Ming-Yii, Cheng Tian-Lu, Wang Jaw-Yuan, Lin Shiu-Ru
Format:	Article
Language:	English
Published:	BMC 2008-02-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/8/50

Similar Items

Polymorphisms in XPD and ERCC1 Associated with Colorectal Cancer Outcome
by: Shiu-Ru Lin, et al.
Published: (2013-02-01)

Correlated X-ray/optical variability in the quasar MR?2251?178
by: Arévalo, P., et al.
Published: (2008)

X-ray observations of SS 433 and the QSO MR 2251-178
by: Pan, Hongchao
Published: (1989)

Cancer stem cell gene profile as predictor of relapse in high risk stage II and stage III, radically resected colon cancer patients.
by: Riccardo Giampieri, et al.
Published: (2013-01-01)

Identification of 42 Genes Linked to Stage II Colorectal Cancer Metastatic Relapse
by: Rabeah A. Al-Temaimi, et al.
Published: (2016-04-01)

Correlation of CTR1, ERCC-1, and HSP70 expressions with cisplastin response in cervical cancer stage IIB
by: Brahmana Askandar, et al.
Published: (2020-01-01)

A Prospective Study of Comparing Multi-Gene Biomarker Chip and Serum Carcinoembryonic Antigen in the Postoperative Surveillance for Patients with Stage I-III Colorectal Cancer.
by: Yu-Tang Chang, et al.
Published: (2016-01-01)

ERCC1 as a marker of prognosis and sensitivity to platinum-based chemotherapy in patients with stage III–IV non-small cell lung cancer
by: O. P. Kolesnik, et al.
Published: (2020-06-01)

Biomarker for colorectal carcinoma -ERCC1-New kid on the block
by: Nalini Bansal
Published: (2019-01-01)

Nomogram for predicting overall survival in stage II‐III colorectal cancer
by: Jungang Liu, et al.
Published: (2020-04-01)

Thymidine Phosphorylase Gene Expression in Stage III Colorectal Cancer
by: Elinor B. Lindskog, et al.
Published: (2012-01-01)

Thymidine Phosphorylase Gene Expression in Stage III Colorectal Cancer
by: Elinor B. Lindskog, et al.
Published: (2012-10-01)

Role of Bruton’s Tyrosine Kinase in Stage III Colorectal Cancer
by: Debora Basile, et al.
Published: (2019-06-01)

Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma
by: A Boland, et al.
Published: (2009-09-01)

Effects of polymorphisms in <it>ERCC1</it>, <it>ASE-1 </it>and <it>RAI </it>on the risk of colorectal carcinomas and adenomas: a case control study
by: Wallin Håkan, et al.
Published: (2006-07-01)

Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer
by: Gang Yang MM, et al.
Published: (2020-08-01)

<it>ERCC2</it>, <it>ERCC1 </it>polymorphisms and haplotypes, cooking oil fume and lung adenocarcinoma risk in Chinese non-smoking females
by: Li Xuelian, et al.
Published: (2009-12-01)

ERCC1 and Class Ⅲ β-tubulin Protein Expression in Relation to Tumour Response and Survival of Stage ⅢB/Ⅳ NSCLC Patients Treated with TP/NP Chemotherapy Regimens
by: Yongying XIAO, et al.
Published: (2009-01-01)

Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis.
by: Yu Xin, et al.
Published: (2014-01-01)

Genetic polymorphisms and haplotypes of ERCC1 and ERCC2 associated with quality of life, depression, and anxiety status among patients with lung cancer
by: Yunxiang Tang, et al.
Published: (2021-07-01)

A robust gene signature for the prediction of early relapse in stage I–III colon cancer
by: Weixing Dai, et al.
Published: (2018-04-01)

High expression of TMEM180, a novel tumour marker, is associated with poor survival in stage III colorectal cancer
by: Takuya Shiraishi, et al.
Published: (2021-03-01)

Vitamin D Status and Survival in Stage II-III Colorectal Cancer
by: Yichao Bao, et al.
Published: (2020-12-01)

Microsatellite instability & survival in patients with stage II/III colorectal carcinoma
by: Markovic Srdjan, et al.
Published: (2016-01-01)

Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer
by: Chen, Y., et al.
Published: (2022)

Impact of ERCC2 Gene Polymorphisms on OSCC Susceptibility and Clinical Characteristics
by: ML Avinash Tejasvi, et al.
Published: (2020-12-01)

High blood sugar levels but not diabetes mellitus significantly enhance oxaliplatin chemoresistance in patients with stage III colorectal cancer receiving adjuvant FOLFOX6 chemotherapy
by: I-Ping Yang, et al.
Published: (2019-08-01)

Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis
by: Haiguang Zhang, et al.
Published: (2017-04-01)

ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers
by: Tarek M. A. Abdel-Fatah, et al.
Published: (2019-08-01)

Preliminary analysis of the effect of Stevia (Stevia rebaudiana) in patients with chronic kidney disease (stage I to stage III)
by: Farhana Rizwan, et al.
Published: (2018-12-01)

Performance of a Nomogram Based on the Integration of Inflammation Markers with Tumor Staging in Prognosis Prediction of Stage III Colorectal Cancer
by: Wang L, et al.
Published: (2020-08-01)

FIVE-YEAR CANCER-SPECIFIC SURVIVAL OF STAGE III COLORECTAL CANCER PATIENTS
by: V. Т. Kokhnyuk
Published: (2015-02-01)

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
by: Florian Posch, et al.
Published: (2018-02-01)

Nutritional status predicts adjuvant chemotherapy outcomes for stage III colorectal cancer
by: Keisuke Ihara, et al.
Published: (2019-04-01)

Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer
by: C. Sarasqueta, et al.
Published: (2019-07-01)

The ZEB2‐dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer
by: Rahul Sreekumar, et al.
Published: (2021-08-01)

ERCC1 and XRCC1 but not XPA single nucleotide polymorphisms correlate with response to chemotherapy in endometrial carcinoma
by: Chen L, et al.
Published: (2016-11-01)

Prognostic Analysis of ERCC1, RRM1 and p53 Expressions in Postoperative Stage Ⅰ-Ⅱ Lung Cancer
by: Baohui HAN, et al.
Published: (2009-05-01)

ERCC1 and ERCC2 variants predict survival in gastric cancer patients.
by: Yangkai Li, et al.
Published: (2013-01-01)

The CYP19 RS4646 polymorphism IS related to the prognosis of stage I-II and operable stage III breast cancer.
by: Xiying Shao, et al.
Published: (2015-01-01)